N.O.Max® acts in synergy with L-arginine to increase the production of endothelium nitric oxide, while providing excellent antioxidant protection to reduce the harmful effects of free radicals in stressful situations like sustained and repeated physical activity. Combining N.O.Max® with L-arginine could help to optimize vasodilation properties and may contribute to improved blood flow. In human clinicals, 500mg and 1000 mg of N.O.Max® taken for 30 days improved vasodilation by 20% to 50%, reducing fasting blood glucose and inflammatory markers.
In a placebo controlled human clinical trial with 237 patients, supplementation with NOMax™ helped maintain healthy blood glucose levels, with an average reduction of 20%.
HP Ingredients offers custom formulations and private labeling services to manufacturers. HPI’s innovation in formulations is accomplished by combining our trademarked ingredients with other clinically tested, well-researched nutraceuticals.